Chugai Venture Fund is a corporate venture capital fund affiliated with Chugai Pharmaceutical that backs pre-seed, early-stage and preclinical life sciences companies in the United States. The fund targets technologies aligned with Chugai’s R&D priorities, including new target identification, platform technologies and therapeutics in biotechnology, pharmaceuticals, oncology and neuroscience-related areas, with relevance to AI-enabled drug discovery. Typical investments are in the mid-single-million-dollar range, with reserves for follow-on capital.